Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
Pascal Pujol(Centre National de la Recherche Scientifique), Julie A. Vendrell(Inserm), Laurence Gladieff(Institut Claudius Regaud), Karim Fizazi(Institut Gustave Roussy), Pierre‐Jean Lamy(Montpellier GenomiX), Jean‐Louis Mandel(Centre National de la Recherche Scientifique), Carole Corsini(Université de Montpellier), Banu Arun(The University of Texas MD Anderson Cancer Center), Helen Hanson(University of Exeter), Karen Baudry(Université de Montpellier), Y. Neuzillet(Université de Versailles Saint-Quentin-en-Yvelines), Josep M. Piulats(Institut Català d'Oncologia), Marion Imbert‐Bouteille(Université de Montpellier), Clare Turnbull(Royal Marsden NHS Foundation Trust), Massimo Barberis(European Institute of Oncology), Clarisse Duriez(ADIR Association), Jesús García‐Foncillas(Hospital Universitario Fundación Jiménez Díaz), William D. Foulkes(McGill University), Eitan Friedman(Sheba Medical Center), Marie Duboys de Labarre(Université de Montpellier), Matti Aapro(Breast Center), Olivier Cussenot(Sorbonne Université), William Jacot(Inserm), Ignace Vergote(KU Leuven), Florence Duchamp(Université de Montpellier), Frédérique Penault‐Llorca(Institut Claudius Regaud), Xavier Rébillard(Clinique du Millénaire), Pascal Hammel(Université Paris Cité), Chloé Rideau(Université de Montpellier), Joseph Gligorov(Sorbonne Université), Philp Beer(Wellcome Sanger Institute), Ettore Capoluongo(Agostino Gemelli University Polyclinic), Isabelle Ray‐Coquard(Centre Léon Bérard), Tatiana Kogut-Kubiak(Université de Montpellier), Sophie Nambot(Inserm), Sylviane Olschwang(Inserm), Diether Lambrechts(KU Leuven), Isabelle Treilleux(Centre Léon Bérard), Thibault De La Motte Rouge(Inserm), Bernard Baertschi(University of Geneva), Virginie Galibert(Université de Montpellier), Michèle Anahory, Steven A. Narod(University of Toronto), Marion Vandromme(ADIR Association), Jean‐Marc Rey(Université de Montpellier), Yves–Jean Bignon(Inserm), Jean-Philippe Spano(Inserm), Nicola Normanno(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Frédéric Thomas(Institut de Recherche pour le Développement), Marc A. Bollet(Clinique Hartmann)
Cited by 174
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k